News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crimson Life Sciences Solves Japanese Translation Dilemma for U.S. Medical Device Manufacturers


5/2/2011 8:22:17 AM

TOKYO--(BUSINESS WIRE)--Crimson Life Sciences, a division of TransPerfect and the world’s only ISO 13485 and ISO 14971-certified translation provider, today announced the opening of a dedicated production facility in Tokyo, Japan. Utilizing TransPerfect’s proprietary GlobalLink™ Translation and Review Portal, Crimson Japan provides a solution for manufacturers who are struggling with translation issues in the challenging Japanese market.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES